BRIEF-Valeant says cannot comment on or speculate about possible course of any ongoing investigation

Wed Aug 10, 2016 10:51pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Aug 10 (Reuters) - Valeant Pharmaceuticals International Inc

* Cannot comment on or speculate about possible course of any ongoing investigation

* Previously disclosed in Oct 2015 that U.S. attorney's office for SDNY commenced investigation involving co

* Comments on SDNY investigation

* Statement on ongoing investigation being conducted by U.S. attorney's office for southern district of New York Source text for Eikon: Further company coverage: